BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1816185)

  • 1. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
    Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
    J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
    Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
    Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of surface hydrophobicity and charge of Staphylococcus aureus treated with sub-MIC of antibiotics and their effects on the chemiluminescence response of phagocytic cells.
    Nomura S; Kuroiwa A; Nagayama A
    Chemotherapy; 1995; 41(2):77-81. PubMed ID: 7758360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus.
    Milatović D
    Eur J Clin Microbiol; 1982 Apr; 1(2):97-101. PubMed ID: 6293812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes.
    Nomura S; Kuroiwa A; Murata K; Nagayama A
    Chemotherapy; 1997; 43(2):132-6. PubMed ID: 9084922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime enhances phagocytosis and intracellular killing of Staphylococcus aureus but does not influence polymorphonuclear leukocytes response to fMLP stimulation.
    Bialasiewicz P; Stolarek R; Wejner P; Piasecka G; Dutkiewicz B; Mikucki J; Nowak D
    Int J Immunopharmacol; 2000 Jul; 22(7):557-66. PubMed ID: 10785552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
    Labro MT; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
    Labro MT; Amit N; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the phagocytic activity of human polymorphonuclear neutrophils induced in vitro by cefotiam vs 6 other antibiotics].
    Arione R; Marietti G; Di Nola F
    Minerva Med; 1987 Jul; 78(13):933-40. PubMed ID: 3299148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
    Shaio MF; Chang FY
    J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
    Wenisch C; Bartunek A; Zedtwitz-Liebenstein K; Hiesmayr M; Parschalk B; Pernerstorfer T; Graninger W
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1584-8. PubMed ID: 9210690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
    Braga PC; Sasso MD; Sala MT
    J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
    Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
    Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
    Braga PC; Dal Sasso M; Mancini L; Sala MT
    Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S; Nagayama A
    Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
    Labro MT; el Benna J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lactoferrin on the phagocytic activity of polymorphonuclear leucocytes isolated from blood of patients with autoimmune diseases and Staphylococcus aureus allergy.
    Manev V; Maneva A; Sirakov L
    Adv Exp Med Biol; 1998; 443():321-30. PubMed ID: 9781376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic efficacy of cefodizime in combination with minocycline against systemic infection caused by methicillin-resistant Staphylococcus aureus in immunocompromised tumour bearing mice].
    Furukawa T; Shimizu C; Uji T; Miyake Y; Hyodo A; Deguchi K
    Jpn J Antibiot; 1993 Apr; 46(4):310-7. PubMed ID: 8515562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of phagocytic and chemiluminescence response of human polymorphonuclear neutrophils.
    Grebner JV; Mills EL; Gray GH; Quie PG
    J Lab Clin Med; 1977 Jan; 89(1):153-9. PubMed ID: 401517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.